5-113513930-C-T

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001345975.2(YTHDC2):​c.-255C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00117 in 1,605,508 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0065 ( 7 hom., cov: 33)
Exomes 𝑓: 0.00062 ( 11 hom. )

Consequence

YTHDC2
NM_001345975.2 5_prime_UTR_premature_start_codon_gain

Scores

1
17

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 1.02
Variant links:
Genes affected
YTHDC2 (HGNC:24721): (YTH N6-methyladenosine RNA binding protein C2) This gene encodes a member of the DEAH (Asp-Glu-Ala-His) subfamily of proteins, part of the DEAD (Asp-Glu-Ala-Asp) box family of RNA helicases. The encoded protein binds to N6-methyladenosine, a common modified RNA nucleotide that is enriched in the stop codons and 3' UTRs of eukaryotic messenger RNAs. Binding of proteins to this modified nucleotide may regulate mRNA translation and stability. This gene may be associated with susceptibility to pancreatic cancer in human patients, and knockdown of this gene resulted in reduced proliferation in a human liver cancer cell line. [provided by RefSeq, Sep 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0046419203).
BP6
Variant 5-113513930-C-T is Benign according to our data. Variant chr5-113513930-C-T is described in ClinVar as [Benign]. Clinvar id is 776057.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00648 (987/152340) while in subpopulation AFR AF= 0.0221 (920/41582). AF 95% confidence interval is 0.0209. There are 7 homozygotes in gnomad4. There are 468 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 987 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
YTHDC2NM_022828.5 linkuse as main transcriptc.35C>T p.Pro12Leu missense_variant 1/30 ENST00000161863.9 NP_073739.3 Q9H6S0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
YTHDC2ENST00000161863.9 linkuse as main transcriptc.35C>T p.Pro12Leu missense_variant 1/301 NM_022828.5 ENSP00000161863.4 Q9H6S0
YTHDC2ENST00000515883.5 linkuse as main transcriptc.35C>T p.Pro12Leu missense_variant 1/171 ENSP00000423101.1 D6RA70
YTHDC2ENST00000503857.5 linkuse as main transcriptn.35C>T non_coding_transcript_exon_variant 1/165 ENSP00000426644.1 D6RF50

Frequencies

GnomAD3 genomes
AF:
0.00648
AC:
987
AN:
152226
Hom.:
7
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0222
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00525
GnomAD3 exomes
AF:
0.00149
AC:
341
AN:
228386
Hom.:
3
AF XY:
0.00113
AC XY:
142
AN XY:
125912
show subpopulations
Gnomad AFR exome
AF:
0.0247
Gnomad AMR exome
AF:
0.000774
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000340
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000599
Gnomad OTH exome
AF:
0.000178
GnomAD4 exome
AF:
0.000617
AC:
896
AN:
1453168
Hom.:
11
Cov.:
31
AF XY:
0.000530
AC XY:
383
AN XY:
722076
show subpopulations
Gnomad4 AFR exome
AF:
0.0226
Gnomad4 AMR exome
AF:
0.00124
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000351
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000153
Gnomad4 OTH exome
AF:
0.00119
GnomAD4 genome
AF:
0.00648
AC:
987
AN:
152340
Hom.:
7
Cov.:
33
AF XY:
0.00628
AC XY:
468
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.0221
Gnomad4 AMR
AF:
0.00340
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00520
Alfa
AF:
0.000277
Hom.:
0
Bravo
AF:
0.00768
ESP6500AA
AF:
0.0181
AC:
71
ESP6500EA
AF:
0.000128
AC:
1
ExAC
AF:
0.00189
AC:
225
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

YTHDC2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 24, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 31, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
21
DANN
Benign
0.90
DEOGEN2
Benign
0.0028
T;T
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.80
T;T
MetaRNN
Benign
0.0046
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.34
N;.
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
-0.78
N;N
REVEL
Benign
0.070
Sift
Benign
0.059
T;T
Sift4G
Benign
0.13
T;T
Polyphen
0.16
B;.
Vest4
0.17
MVP
0.043
MPC
0.095
ClinPred
0.031
T
GERP RS
3.6
Varity_R
0.039
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs116615892; hg19: chr5-112849627; API